|
|||||
|
|
A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study |
|
| Authors: | Vici P Giotta F Di Lauro L Sergi D Vizza E Mariani L Latorre A Pizzuti L D'Amico C Giannarelli D Colucci G |
| Affiliation: | Division of Medical Oncology B, Regina Elena National Cancer Institute, Rome, Italy. pvici@ifo.it |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |